You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

natalizumab

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial (Natalizumab)

Not yet recruiting
  • Multiple Sclerosis
  • Natalizumab
  • (no location specified)
Jun 21, 2023

End of Dose Phenomena in Subcutaneous Natalizumab Treated

Not yet recruiting
  • Multiple Sclerosis
  • Natalizumab
  • (no location specified)
Jan 18, 2023

Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

Not yet recruiting
  • Sickle Cell Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 8, 2022

MS Had Greater Than 60 Infusions of Natalizumab

Active, not recruiting
  • Multiple Sclerosis
  • Natalizumab
  • Latham, New York
    Multiple Sclerosis Center of Northeastern New York, P.C.
Mar 23, 2022

Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)

Recruiting
  • Schizophrenia
  • Natalizumab
  • Placebo: normal saline
  • London, United Kingdom
    Institute of Psychiatry, Psychology and Neuroscience, King's Col
Sep 27, 2022

Multiple Sclerosis Trial in Czechia (Natalizumab)

Recruiting
  • Multiple Sclerosis
  • Natalizumab
  • Brno, Czechia
  • +14 more
Feb 2, 2022

Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate

Recruiting
  • Multiple Sclerosis
  • Diroximel Fumarate
  • +8 more
  • Eden Prairie, Minnesota
    OptumInsight
Jan 9, 2023

Acute GVHD Trial in United States (natalizumab, steroids)

Active, not recruiting
  • Acute Graft Versus Host Disease
  • Duarte, California
  • +11 more
Oct 15, 2021

Epilepsy, Focal Seizures, Partial Seizures Trial in United States (Natalizumab, Placebo)

Completed
Has Results
  • Epilepsy, Focal Seizures, Partial Seizures
  • Natalizumab
  • Placebo
  • Birmingham, Alabama
  • +30 more
Nov 17, 2021

Multiple Sclerosis Trial in Buffalo (Natalizumab)

Recruiting
  • Multiple Sclerosis
  • Natalizumab
  • Buffalo, New York
    SUNY Buffalo
Oct 5, 2020

Tysabri in Early Relapsing Remitting Multiple Sclerosis

Active, not recruiting
  • Relapsing Remitting Multiple Sclerosis
  • Natalizumab
  • Amadora, Portugal
  • +17 more
Apr 12, 2022

A Study for Tysabri Participant Preference

Recruiting
  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Natalizumab
  • Augsburg, Germany
  • +39 more
Mar 22, 2022

GVHD Trial in Boston (Natalizumab, Methylprednisolone)

Completed
Has Results
  • Graft Versus Host Disease
  • Boston, Massachusetts
  • +1 more
Apr 7, 2020

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Natalizumab)

Active, not recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Natalizumab
  • Cullman, Alabama
  • +96 more
Sep 17, 2020

Multiple Sclerosis Trial in Netherlands (Natalizumab)

Completed
  • Multiple Sclerosis
  • Natalizumab
  • Amsterdam, Netherlands
  • +4 more
Jul 11, 2019

Clinical Disease Activity With Long Term Natalizumab Treatment

Completed
  • Relapsing-Remitting Multiple Sclerosis
  • natalizumab
  • Brussels, Belgium
  • +3 more
Jan 3, 2019

EDSS With Quality of Life in MS Participants Treated With

Completed
  • Multiple Sclerosis
  • natalizumab
  • Aarau, Switzerland
  • +6 more
Sep 12, 2018

Acute Ischemic Stroke Trial in Worldwide (natalizumab, Placebo)

Completed
Has Results
  • Acute Ischemic Stroke
  • natalizumab
  • Placebo
  • Los Angeles, California
  • +52 more
Dec 18, 2018

Relapsing Multiple Sclerosis Trial in United States (natalizumab)

Terminated
Has Results
  • Relapsing Multiple Sclerosis
  • natalizumab
  • Fullerton, California
  • +10 more
Apr 24, 2017

Inclusion Body Myositis (IBM) Trial in Phoenix (Natalizumab)

Unknown status
  • Inclusion Body Myositis (IBM)
  • Natalizumab
  • Phoenix, Arizona
    Phoenix Neurological Insitutute
Feb 8, 2017

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (natalizumab, fingolimod)

Terminated
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Aurora, Colorado
  • +41 more
May 17, 2017

Relapsing Multiple Sclerosis Trial in Leuven, Liege (natalizumab)

Terminated
  • Relapsing Multiple Sclerosis
  • natalizumab
  • Leuven, Belgium
  • +1 more
Sep 27, 2016

Secondary Progressive Multiple Sclerosis Trial in Worldwide (natalizumab, Placebo)

Terminated
Has Results
  • Secondary Progressive Multiple Sclerosis
  • natalizumab
  • Placebo
  • Phoenix, Arizona
  • +160 more
Aug 10, 2017

Crohn's Disease Trial (natalizumab)

Withdrawn
  • Crohn's Disease
  • natalizumab
  • (no location specified)
Jun 14, 2016

Crohn's Disease Trial (natalizumab)

Completed
  • Crohn's Disease
  • natalizumab
  • (no location specified)
Jun 14, 2016